Aims To illustrate how Bayes factors are important for determining the effectiveness of interventions. Method We consider a case where inappropriate conclusions were drawn publicly based on significance testing, namely the SIPS project (Screening and Intervention Programme for Sensible drinking), a pragmatic, cluster-randomized controlled trial in each of two health-care settings and in the criminal justice system. We show how Bayes factors can disambiguate the non-significant findings from the SIPS project and thus determine whether the findings represent evidence of absence or absence of evidence. We show how to model the sort of effects that could be expected, and how to check the robustness of the Bayes factors. Results The findings from the three SIPS trials taken individually are largely uninformative but, when data from these trials are combined, there is moderate evidence for a null hypothesis (H0) and thus for a lack of effect of brief intervention compared with simple clinical feedback and an alcohol information leaflet (B = 0.24, P = 0.43).
INTRODUCTION
The dominant approach to statistical inference in randomized controlled trials (RCTs) in addiction and related sciences is null hypothesis significance testing (NHST). However, when no significant differences are found on outcome measures between intervention and control groups, NHST is crucially uninformative [1] . It is unable to distinguish between two interpretations of non-significant findings: (i) there is no evidence that the population means of the groups differ (absence of evidence) or (ii) there is evidence that the population means do not differ (evidence of absence) [2] . The present paper provides an illustration of this use of Bayes factors to address this problem.
When Fisher introduced significance testing he made clear that one should suspend judgement if findings are non-significant [3, 4] . However, instances of using nonsignificance to assert the null hypothesis are still found frequently in the literature [5] . This cannot be regarded as an arcane or trivial matter. The SSRI paroxetine was stated originally to carry no increased risk of suicide in children on the basis of a non-significant result, but was found later to contain such a risk ( [6] , pp. 59-62).
There are two unfortunate consequences of the inability of NHST to demonstrate evidence of absence. First, where absence of evidence is concluded from nonsignificant findings, there may nevertheless have been good evidence that the postulated effect did not exist if the data had been evaluated in an informative way. Thus, where a conclusion may be warranted, the data and information available are wasted. Secondly, when evidence of absence is concluded incorrectly under NHST, there may nevertheless be a real effect of intervention in the population and, in this situation, an opportunity to support an effective intervention by further research will have been missed. Both these kinds of negative consequence will have had retarding effects on theory, research and practice (a problem not fully addressed by power [5] ).
A solution to this problem would be a method of statistical inference that gave an actual degree of evidence for the alternative versus the null hypothesis. Such a method is provided by Bayes factors [7, 8] . While under NHST only two conclusions are possible from the results of an RCTeither the null hypothesis is rejected or it is not-from a Bayesian perspective, there are three conclusions: (i) there is sufficient evidence for the alternative hypothesis that, for example, an intervention has an effect on participants' behaviour; (ii) there is sufficient evidence for the null hypothesis that the intervention has no effect over the alternative considered; and (iii) the data are insensitive in distinguishing the hypotheses.
To determine which of these conclusions applies to any given data set, one calculates the Bayes factor (B). This is the ratio of how well the observed data are predicted by the alternative hypothesis over how well they are predicted by the null hypothesis. If this ratio is greater than 1, the alternative hypothesis is to that degree supported over the null hypothesis; if it is less than 1, the null hypothesis is supported over the alternative; and if it is approximately 1, neither hypothesis is supported more than the other. To arrive at a decision in practice, recommended cut-offs [1, 9] are that B greater than 3 represents 'substantial' [9] (or better 'moderate' [10] ) evidence for the alternative hypothesis and B less than one-third represents 'substantial' (or 'moderate') evidence for the null hypothesis, with values in between representing a range of weak evidence for either hypothesis depending on whether B is greater or less than 1. A B of 3 has been shown to correspond roughly with a P-value of 0.05 in conventional statistical testing [1] .
The SIPS project
This project consisted of a pragmatic, cluster RCT in each of two health-care settings, primary health care (PHC) and accident and emergency services (A&E), and a similar trial in the criminal justice system (CJS). Each trial had a 'stepup' design involving three groups in which components were added successively: (i) a control group consisting of the provision of a Patient Information Leaflet (PIL) together with brief feedback of screening results (i.e. whether or not the patient was drinking at a hazardous or harmful level); (ii) a brief advice group consisting of 5 minutes of structured advice about drinking plus the PIL; and (iii) a brief life-style counselling group consisting of 20 minutes of counselling preceded by brief advice and followed by the PIL, and given to those patients who returned for a subsequent consultation following the brief advice session. The hypotheses tested were that both interventions would result in greater reductions in hazardous or harmful drinking than simple clinical feedback of screening results and alcohol information provided by the PIL.
The primary outcome measure in all three trials was whether or not the score on the Alcohol Use Disorders Identification Test (AUDIT) [11] was above the cut-point for a designation of hazardous drinking. The main analysis was by intention-to-treat, but there was also a per-protocol analysis which included only those patients who had received a complete intervention and were followed-up successfully. For further details of all three trials, including large sample sizes and high follow-up rates, see the corresponding protocol [12] [13] [14] and outcome papers [15] [16] [17] .
In each trial all three groups showed reductions in the proportion of participants classified as hazardous drinkers or worse by the AUDIT, but there were no statistically significant differences between groups on this measure at either 6-or 12-month follow-up in any of the three trials [2] [3] [4] . This applied to both intentionto-treat and per-protocol analyses; neither were there significant differences between groups on any other alcohol outcome measure (i.e. mean AUDIT score or extent of alcohol problems).
Heather [18] discussed several ways in which the SIPS findings had been misunderstood, and the potential effects on research and practice. A prime example of 'proving the null hypothesis' appeared in an article [19] in the magazine Pulse, which is read widely by general practitioners (GPs) and other health professionals. The article began: 'GPs should give patients with problem drinking a leaflet rather than advise them to reduce their alcohol intake', because: 'The SIPS (PHC) study found informing patients of their drinking levels and offering a leaflet… was just as effective as giving patients five-or 10-minutes of lifestyle counselling'.
Aims
The aims of the analysis reported here were: (i) to calculate Bayes factors in order to disambiguate non-significant findings from the SIPS project and thus determine whether they represent evidence of absence or absence of evidence; and (ii) to illustrate how Bayes factors can clarify nonsignificant findings.
METHOD
A Bayes factor requires a summary of the data [a measure of effect size such as a mean difference or an odds ratio (OR), plus the standard error (SE) of that estimate] and in addition a specification of the size of effect predicted. One cannot tell how sensitive a study was to detect an effect without an idea of the size of effect that is possible [4] . To be more precise, the relative evidence for H1 versus H0 provided by the data depends upon how well the data are predicted by H1 versus how well the data are predicted by H0 [20] . To know how well the data are predicted by H1, we need a model of H1: a specification of what (range of) effect sizes are plausible according to H1 [21] .
In a meta-analytical review of the effect of brief interventions on the proportion of hazardous drinkers (i.e. the same dependent variable as used in SIPS), Ballesteros et al. [22] found that brief interventions outperformed minimal interventions and usual care after 6-12 months with OR = 1.55 [with a 95% confidence interval (CI) = 1.2, 1.90]. In a previous meta-analysis of brief interventions for alcohol use disorders using a wider range of dependent variables, Moyer et al. [23] found an average effect size of d = 0.2 for drinking-related outcomes, including alcohol consumption, for a brief intervention versus a control at 6 months (with a CI from approximately 0.1 to 0.3, depending on the exact outcome). Assuming an underlying continuous variable given a binary cut-off, this can be converted to Ln OR = d × π/√3 [24] or a Ln OR of 0.36 in this case, which is an OR of 1.4. A standardized effect size is a measure of signal relative to noise; and the amount of noise in a study depends on the details of the experimental design and the precise dependent variable used. Translating effect sizes between different dependent variables should therefore be performed cautiously. However, the fact that the two meta-analyses above produce very similar estimates (OR = 1.4 versus 1.55) is reassuring. Thus, we will take the estimate from the meta-analysis [22] based on the same dependent variable as we analyse here, an OR of 1.55, i.e. ln OR = 0.44, as a plausible scale of effect for our brief interventions versus the PIL.
We have estimated a rough scale of the effect size, but effects smaller or bigger than this are also plausible. Published effects often overestimate the true population effect size, as indicated by systematic direct replication attempts in psychology and other disciplines [25] [26] [27] . One simple way of modelling this assumption is with a bell-shaped distribution; for example, a normal distribution, centred on zero. Because we are making predictions in one direction one half of the distribution can be removed to leave, for example, a half-normal distribution. For a half-normal there is one parameter left to decide, its standard deviation (SD). We scale using the rough effect size already derived, namely SD = 0.44.
If a normal or half-normal distribution is used, the scale factor implies a rough maximum, namely twice the standard deviation, as there is only 5% probability of an effect larger than that. Another distribution often used in Bayes factors is a Cauchy [8] ; the rough maximum implied by a Cauchy is seven times its scale factor (with 5% of its area beyond that), so the final decision to make concerns what defines a just-plausible maximum more adequately, 2*0.44 or 7*0.44 (corresponding to ORs of 2.4 and 21.8, respectively (see [28] ). Given that the confidence interval on the effect sizes reviewed in Ballesteros et al. [22] and Moyer et al. [23] (and see Wilk et al. [29] ) were less than twice the mean estimated effect, the half-normal is more appropriate than the half-Cauchy.
In sum, we use a half-normal model of H1 because it respects two general assumptions: (i) that smaller effects are more likely than larger ones; and (ii) that twice the estimated scale of effect is a rough plausible maximum. We report a check on the robustness of our assumptions below. We notate using a half-normal with an SD of 0.44 to model H1 as B H(0, 0.44) , the H to indicate a half-normal, the 0 indicates its mode is 0 and the 0.44 indicates the standard deviation (for notation see [1] ). (If there were several theories we could use a Bayes factor to test each against H0 separately.) Table 1 shows the results for the three trials at 6 months follow-up, the primary end-point. While the Bayes factors for the individual trials on their own largely indicate insensitive evidence, the effect of the data as a whole needs to be evaluated by combining the mean estimates of the ln OR. This can be performed using, for example, the calculator from Dienes [7] (http://www.lifesci.sussex.ac.uk/home/ Zoltan_Dienes/inference/Bayes.htm 1 ) for obtaining a posterior distribution, 2,3 which provides the results in the final two rows. The effect of a brief intervention may be specific to its setting of implementation. For example, the motivation for changing drinking is likely to differ between medical patients and offenders. The Kaner team's two Cochrane reviews of the effects of alcohol brief intervention [30, 31] combine primary care and A&E on the grounds that, under a wider definition, both are considered forms of primary health care. The difference between brief advice versus PIL between the PHC and A&E trials was 0.26 (SE = 0.67), B N(0, 0.44) = 0.86 4 ; that is, there is no evidence one way or the other for a difference between these studies. The estimates are combined in the penultimate row of Table 1 . Similarly, for brief life-style counselling versus PIL, the difference between the PHC and A&E trials was 0.46 (SE = 0.74), B N(0, 0.44) = 0.90; again, no evidence one way or the other for a difference between the two studies. The penultimate row in Table 1 indicates the importance of combining data meta-analytically. While each study alone did not lead to clear conclusions, overall there is moderate evidence for no effect of the brief interventions compared to control (i.e. Bayes factor less than approximately one-third), assuming the sort of effect sizes that have been found before for such brief interventions.
RESULTS
Finally, one may wonder how strong the evidence is when all studies are combined. There was no evidence for a difference between CJS and the combined PHC/A&E for brief advice versus PIL, 0. Table 1 indicates moderate evidence for no effect of the brief interventions compared to control for the combined data and for both comparisons, assuming the sort of effect sizes that have been found before for such brief interventions.
The conclusion is relative to the model of H1 used. The robustness of the conclusion can be checked by determining if the same conclusion follows for different ways of representing the same scientific judgements. We used the review by Ballesteros and colleagues [22] for informing the use of a half-normal distribution; that is, this paper played a key role in our scientific judgements. We might also have used the posterior distribution of the effect size presented by Ballesteros et al. as our model of H1 (e.g. [32] ). Ballesteros et al. estimated the ln OR as Ln(1.55) with an SE of 0.21. Thus, using the Dienes [7] calculator, H1 could be modelled by a normal distribution with a mean of 0.44 and an SD of 0.21. For BA versus PIL, B N(0.44,0.21) = 0.10 and for BLC versus PIL, B N(0.44,0.21) = 0.09. In both cases the conclusion remains the same. Thus, the difference in representations of H1 did not change the conclusion substantially. We may also perform a sensitivity analysis with the half-normal representation to determine how conclusions depend upon its standard deviation. Any adjustment to allow the effect to be plausibly larger than we have represented will increase support for H0, leading to the same conclusion. Conversely, if one had good reason, independent of the current data, to doubt the effect could be as large as we have represented, that information could render the evidence insensitive. Specifically, with a half-normal presenttion, if the estimated effect was as low as 0.24, the Bayes factor for BLC versus 1 Archived here: http://www.webcitation.org/6s4eJTOTs on 19 July 2017. 2 The calculator assumes all data are estimates of the same population effect. H0 postulates a fixed effect (namely, no effect). Thus, for hypothesis testing, a fixed-effects analysis typically serves adequately, because if H0 can be rejected on that basis it can be rejected. For estimation, by contrast, it makes sense to take into account the uncertainty in whether the different trials were drawn from the same population, a possibility not denied a priori by a tested hypothesis. 3 The posterior distribution represents how probable different population effect sizes are, in the light of data. 4 H1 is modelled as a normal here, hence the 'N' in the notation. This allows the theoretical difference between conditions to go in either direction. BA = brief advice; BLC = brief life-style counselling; PIL = patient information leaflet; CJS = criminal justice system; A&E = accident and emergency; CI = confidence interval; SE = standard error; PHC = primary health care.
PIL is 0.33. When using 0.24 as the SD of a half-normal, the maximum plausible Ln (OR) is approximately twice the SD, 0.48 (i.e. the maximum plausible OR is 1.6). That is, the evidence becomes relatively insensitive if an effect above about 0.48 can be ruled out. However, based on the meta-analytical reviews we have referred to, the current scientific judgement is that the effect could well be larger than this, so our conclusions stand. Further investigation into, for example, missing studies, the role of the significance filter or the role of analytical flexibility in each study may refine the meta-analyses, and thus change our best scientific judgements about effects. The Bayes factor stands as a provisional judgement, given the current state of evidence. For reference, Table 2 presents the same statistics for the same dependent variable at 12 months. A similar pattern emerges.
DISCUSSION
We show that non-significant results from a family of trials involving a large number of participants do not provide compelling evidence for no effect, despite the way in which the trial results have, in fact, been interpreted to justify claims of the lack of effectiveness of the interventions. For individual published trials, the results were scarcely moderate evidence for the null hypothesis over a plausible alternative. A problem arises from taking non-significance to mean evidence for H0. Even a high-powered nonsignificant result does not necessarily mean that there is evidence for the null hypothesis over the alternative [28] . However, we also showed that taking a key two trials, or else all three, in the family of trials together provided moderate evidence for no effect of brief advice or brief life-style counselling over simple clinical feedback and an alcohol information leaflet at 6 months' follow-up compared to the size of effect one might expect, given meta-analyses of brief interventions. There was also moderate evidence for no effect of brief life-style counselling at 12 months' follow-up. Thus, combining data is useful not just for establishing that there is an effect, but in establishing that there is not. These conclusions did not follow from the mere fact of obtaining non-significant results; they had to be argued carefully. Further, for each study taken separately, as yet the evidence is not there one way or the other; this conclusion itself depends upon using Bayes factors and does not follow from P-values alone.
Addiction recommends that authors do not report no difference for non-significant findings unless a Bayes factor has been calculated [2] . In a recent analysis of papers in Addiction, only 20% of non-significant findings in a sample of randomized controlled trials were evidence of no effect [33] .
A Bayes factor compares how well one model predicts the data (e.g. H1) compared to another model (e.g. H0). The axioms of probability show that this is exactly the amount by which one should change one's degree of belief in H1 over H0. Given that evidence is defined as the amount by which one should change belief, the Bayes factor is a measure of strength of evidence [20] ; and given that the models are adequate approximations of the scientific theories they represent, there is thus the guarantee from the axioms of probability that the corresponding Bayes factor is a measure of the strength of evidence for the theory of, for example, an effect of a brief intervention over the theory that the intervention is ineffective.
To model H1, we followed the recommendation of Dienes & McLatchie [28] of using a half-normal with the SD set by prior research, in our case by a relevant metaanalysis. The model is based on simple assumptions and the results of other studies; in that sense it is objective, but further evidence concerning what the theory should predict may revise the outcome.
We modelled H0 as the point prediction of absolutely no difference. It might be objected that this H0 must be wrong; there is never no difference between groups, but the question is whether the model is a good enough approximation, not that it is absolutely true. For example, the assumption of a normal distribution is never absolutely true for any real study; but the issue is whether or not it is a good enough approximation. Instead of a point null hypothesis we could use an interval null hypothesis [1, 34] . Would an odds ratio between 0.95 and 1.05 be so small as to indicate that the intervention was not worth the cost? If so, instead of a point null, we can set a uniform distribution over the null region [ln (0.95), ln(1.05)] as the model of H0. With this null region hypothesis, the above Bayes factors remain the same to within 0.01. That is, the point null hypothesis was a good enough approximation.
Further discussion of the implications of this analysis for research and practice of alcohol brief interventions may be found in Supporting Information, Appendix S1. Scientific inference always depends upon extra-statistical considerations, such as what control groups are appropriate, and the relation of statistical models to theory [5] .
CONCLUSIONS
We recommend that scientists who find non-significant results should suspend judgement-unless they calculate a Bayes factor to indicate either that there is evidence for H0 over a (well-justified) H1, or that indeed more data are needed [33, 35] . The present analysis suggests that the findings from the three SIPS trials taken individually are largely uninformative but that, when data from these trials are combined, there is moderate evidence for a lack of effect of brief intervention in the SIPS trials. We recommend Bayes factor to be used as standard in clinical trials -and, indeed, in all hypothesis tests. 5 Declaration of interests S.C. and N.H. were Principal Investigators on the SIPS project but have no other potential conflicts of interest to declare. Z.D. has no conflicts of interest to declare.
